Inside informationEnglish
THX Pharma (Theranexus) and Exeltis secure EMA approval of the paediatric investigation plan (PIP) for TX01, unlocking the PUMA registration pathway
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- THX Pharma
- Filed
- 09/06/2026, 18:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 080037_20260609